Evaluating Australia's National Medicines Policy using geographical mapping

被引:0
|
作者
Roughead, EE
Monteith, GR
Harvey, KJ
Tett, SE
机构
[1] Univ S Australia, Sch Pharmaceut Mol & Biomed Sci, Adelaide, SA 5000, Australia
[2] Univ Queensland, Sch Pharm, St Lucia, Qld 4067, Australia
[3] La Trobe Univ, Sch Publ Hlth, Bundoora, Vic, Australia
关键词
evaluation; National Medicinal Drug Policy; rational drug use;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There has been a proliferation of quality use of medicines activities in Australia since the 1990s. However, knowledge of the nature and extent of these activities was lacking. A mechanism was required to map the activities to enable their coordination. Aims: To develop a geographical mapping facility as an evaluative tool to assist the planning and implementation of Australia's policy on the quality use of medicines. Methods: A web-based database incorporating geographical mapping software was developed. Quality use of medicines projects implemented across the country was identified from project listings funded by the Quality Use of Medicines Evaluation Program, the National Health and Medical Research Council, Mental Health Strategy, Rural Health Support, Education and Training Program, the Healthy Seniors Initiative, the General Practice Evaluation Program and the Drug Utilisation Evaluation Network. In addition, projects were identified through direct mail to persons working in the field. Results: The Quality Use of Medicines Mapping Project (QUMMP) was developed, providing a Web-based database that can be continuously updated. This database showed the distribution of quality use of medicines activities by: (i) geographical region, (ii) project type, (iii) target group, (iv) stakeholder involvement, (v) funding body and (vi) evaluation method. At September 2001, the database included 901 projects. Sixty-two per cent of projects had been conducted in Australian capital cities, where approximately 63% of the population reside. Distribution of projects varied between States. In Western Australia and Queensland, 36 and 73 projects had been conducted, respectively, representing approximately two projects per 100 000 people. By comparison, in South Australia and Tasmania approximately seven projects per 100 000 people were recorded, with six per 100 000 people in Victoria and three per 100 000 people in New South Wales. Rural and remote areas of the country had more limited project activity. Conclusions: The mapping of projects by geographical location enabled easy identification of high and low activity areas. Analysis of the types of projects undertaken in each region enabled identification of target groups that had not been involved or services that had not yet been developed. This served as a powerful tool for policy planning and implementation and will be used to support the continued implementation of Australia's policy on the quality use of medicines.
引用
收藏
页码:66 / 71
页数:6
相关论文
共 50 条
  • [21] Integrating obesity medicines in the national list of essential medicines: a policy concern
    Sindhwani, Ritika
    Bora, Kundan Singh
    Hazra, Subhajit
    CURRENT SCIENCE, 2024, 127 (06): : 660 - 661
  • [22] National Medicines Policy 2.0: a vision for the future
    McLachlan, Andrew J.
    Aslani, Parise
    AUSTRALIAN PRESCRIBER, 2020, 43 (01) : 24 - 26
  • [23] National medicines policy development, Saudi Arabia
    Almoteiry, Khalid
    Alharf, Adel
    Al Hammad, Bandar
    Aljuffali, Ibrahim
    Al-Azemi, Nahar
    Al-Ghaith, Taghred
    Alhomidi, Shahad
    Alshehri, Ahlam
    Seiter, Andreas
    Herbst, Christopher
    Pisani, Elizabeth
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2022, 100 (08) : 511 - 519
  • [24] Evaluation of access to high-cost medicines in Australia using national claims data
    Lu, CY
    Williams, K
    Day, R
    VALUE IN HEALTH, 2005, 8 (06) : A28 - A28
  • [26] Australia's national urban policy: The smart cities agenda in perspective
    Hu, Richard
    AUSTRALIAN JOURNAL OF SOCIAL ISSUES, 2020, 55 (02) : 201 - 217
  • [27] How Australia came to have a national women's health policy
    Gray, G
    INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1998, 28 (01): : 107 - 125
  • [28] The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil
    Figueiredo, Tatiana Aragao
    de Andrade Schramm, Joyce Mendes
    Edais Pepe, Vera Lucia
    CADERNOS DE SAUDE PUBLICA, 2017, 33 (09):
  • [29] AUSTRALIA'S POSITION ON MEDICINES POLICY IN INTERNATIONAL FORUMS: INTELLECTUAL PROPERTY PROTECTION AND PUBLIC HEALTH
    Legge, David G.
    Gleeson, Deborah H.
    Loefgren, Hans
    Townsend, Belinda
    JOURNAL OF AUSTRALIAN POLITICAL ECONOMY, 2014, (73): : 103 - 131
  • [30] Enhancing Taiwan's healthcare sustainability: A Delphi study on national medicines policy reforms
    Huang, Chih-Fen
    Chen, Kuan-Lin
    Lin, Fang-Ju
    Wang, Chi-Chuan
    Gau, Churn-Shiouh
    Shen, Li-Jiuan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 : S169 - S179